ALXO logo

ALX Oncology Holdings (ALXO) Cash From Operations

Annual CFO

-$121.91 M
+$8.45 M+6.48%

December 31, 2024


Summary


Performance

ALXO Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALXOcash flowmetrics:

Quarterly CFO

-$32.05 M
-$6.67 M-26.28%

December 31, 2024


Summary


Performance

ALXO Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALXOcash flowmetrics:

TTM CFO

-$121.91 M
+$7.63 M+5.89%

December 31, 2024


Summary


Performance

ALXO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALXOcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ALXO Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.5%0.0%0.0%
3 y3 years-79.0%-55.0%-45.8%
5 y5 years-755.6%-524.1%-253.8%

ALXO Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-79.0%+6.5%-88.5%+19.2%-79.0%+13.2%
5 y5-year-755.6%+6.5%-1015.0%+19.2%-755.6%+13.2%
alltimeall time-824.3%+6.5%-1015.0%+19.2%-3057.5%+13.2%

ALX Oncology Holdings Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$121.91 M(-6.5%)
-$32.05 M(+26.3%)
-$121.91 M(-5.9%)
Sep 2024
-
-$25.38 M(-4.5%)
-$129.54 M(-4.3%)
Jun 2024
-
-$26.57 M(-29.9%)
-$135.33 M(-3.7%)
Mar 2024
-
-$37.92 M(-4.4%)
-$140.47 M(+7.8%)
Dec 2023
-$130.36 M(+46.1%)
-$39.68 M(+27.3%)
-$130.36 M(+17.1%)
Sep 2023
-
-$31.16 M(-1.7%)
-$111.35 M(+0.2%)
Jun 2023
-
-$31.71 M(+14.0%)
-$111.08 M(+15.3%)
Mar 2023
-
-$27.82 M(+34.6%)
-$96.36 M(+8.0%)
Dec 2022
-$89.22 M(+31.0%)
-$20.67 M(-33.1%)
-$89.22 M(+3.7%)
Sep 2022
-
-$30.88 M(+81.7%)
-$86.04 M(+7.5%)
Jun 2022
-
-$17.00 M(-17.8%)
-$80.02 M(-4.3%)
Mar 2022
-
-$20.67 M(+18.2%)
-$83.64 M(+22.8%)
DateAnnualQuarterlyTTM
Dec 2021
-$68.10 M(+77.9%)
-$17.49 M(-29.6%)
-$68.10 M(+6.0%)
Sep 2021
-
-$24.86 M(+20.5%)
-$64.23 M(+31.3%)
Jun 2021
-
-$20.62 M(+301.6%)
-$48.92 M(+42.0%)
Mar 2021
-
-$5.13 M(-62.3%)
-$34.46 M(-10.0%)
Dec 2020
-$38.29 M(+168.7%)
-$13.62 M(+42.6%)
-$38.29 M(+39.0%)
Sep 2020
-
-$9.55 M(+54.9%)
-$27.55 M(+30.0%)
Jun 2020
-
-$6.16 M(-31.2%)
-$21.19 M(+9.5%)
Mar 2020
-
-$8.96 M(+211.9%)
-$19.35 M(+35.8%)
Dec 2019
-$14.25 M(+8.0%)
-$2.87 M(-9.8%)
-$14.25 M(+25.3%)
Sep 2019
-
-$3.19 M(-26.4%)
-$11.38 M(+38.9%)
Jun 2019
-
-$4.33 M(+12.1%)
-$8.19 M(+112.1%)
Mar 2019
-
-$3.86 M
-$3.86 M
Dec 2018
-$13.19 M
-
-

FAQ

  • What is ALX Oncology Holdings annual cash flow from operations?
  • What is the all time high annual CFO for ALX Oncology Holdings?
  • What is ALX Oncology Holdings annual CFO year-on-year change?
  • What is ALX Oncology Holdings quarterly cash flow from operations?
  • What is the all time high quarterly CFO for ALX Oncology Holdings?
  • What is ALX Oncology Holdings quarterly CFO year-on-year change?
  • What is ALX Oncology Holdings TTM cash flow from operations?
  • What is the all time high TTM CFO for ALX Oncology Holdings?
  • What is ALX Oncology Holdings TTM CFO year-on-year change?

What is ALX Oncology Holdings annual cash flow from operations?

The current annual CFO of ALXO is -$121.91 M

What is the all time high annual CFO for ALX Oncology Holdings?

ALX Oncology Holdings all-time high annual cash flow from operations is -$13.19 M

What is ALX Oncology Holdings annual CFO year-on-year change?

Over the past year, ALXO annual cash flow from operations has changed by +$8.45 M (+6.48%)

What is ALX Oncology Holdings quarterly cash flow from operations?

The current quarterly CFO of ALXO is -$32.05 M

What is the all time high quarterly CFO for ALX Oncology Holdings?

ALX Oncology Holdings all-time high quarterly cash flow from operations is -$2.87 M

What is ALX Oncology Holdings quarterly CFO year-on-year change?

Over the past year, ALXO quarterly cash flow from operations has changed by $0.00 (0.00%)

What is ALX Oncology Holdings TTM cash flow from operations?

The current TTM CFO of ALXO is -$121.91 M

What is the all time high TTM CFO for ALX Oncology Holdings?

ALX Oncology Holdings all-time high TTM cash flow from operations is -$3.86 M

What is ALX Oncology Holdings TTM CFO year-on-year change?

Over the past year, ALXO TTM cash flow from operations has changed by $0.00 (0.00%)